C07C 235/62
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
C07C235/62 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 47 US grants and 45 published applications in this corpus.
Search patents in C07C- Granted patents
- 47
- Published applications
- 45
- Assignees
- 35
- Inventors
- 198
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 4 | 1 |
| 2004 | 3 | 1 |
| 2005 | 2 | 2 |
| 2006 | 1 | 3 |
| 2007 | 2 | 2 |
| 2008 | 0 | 0 |
| 2009 | 3 | 3 |
| 2010 | 3 | 4 |
| 2011 | 1 | 6 |
| 2012 | 5 | 3 |
| 2013 | 5 | 2 |
| 2014 | 2 | 5 |
| 2015 | 0 | 1 |
| 2016 | 3 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 0 | 3 |
| 2025 | 2 | 0 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Resorcinol-based compounds and uses thereof28 Apr 2026US 12,612,358 B2Organix, Inc.
- 4-membered ring carboxamides used as nematicides6 Jan 2026US RE50,724 E1Syngenta Crop Protection AG
- Inhibitors of the Wnt/beta-catenin pathway2 Sep 2025US 12,404,243 B2The Regents of the University of California
- Cannabinoid derivatives10 Jun 2025US 12,325,709 B2Canopy Growth Corporation
- Inhibitors of the WNT/beta-catenin pathway25 Jul 2023US 11,708,329 B2The Regents of the University of California
- Resorcinol-based compounds and uses thereof22 Feb 2024US 2024/0059646 A1Organix, Inc.
- Inhibitors of the wnt/beta-catenin pathway22 Feb 2024US 2024/0059654 A1The Regents of the University of California
- Compounds and compositions as modulators of tlr signaling8 Feb 2024US 2024/0043395 A1Neuropore Therapies, Inc.
- Adamantane compound, organic electroluminescent device, and electronic apparatus16 Nov 2023US 2023/0365495 A1Hodogaya Chemical Co., Ltd.
- Cannabinoid derivatives14 Sep 2023US 2023/0286906 A1Canopy Growth Corporation
Most cited
By later US patents
- 3,4-disubstituted phenols-immunomodulating agents38US 5,258,407 ASterling Winthrop Inc. · 1993
- Acylaminosalicylic acid amides and their uses as pesticides30US 6,001,879 ABayer Aktiengesellschaft · 1999
- Carboxylic acid derivatives22US 5,385,917 AMitsubishi Kasei Corporation · 1995
- 3,4-disubstituted phenols-immunomodulating agents22US 5,466,715 ASterling Winthrop Inc. · 1995
- Acylaminosalicylic acid amides and their uses as pesticides18US 6,548,549 B1Bayer Aktiengesellschaft · 2003